Sen. Wyden Hails New CBO Report on High Drug Prices
January 20, 2022
January 20, 2022
WASHINGTON, Jan. 20 (TNSRep) -- Sen. Ron Wyden, D-Oregon, chairman of the Senate Finance Committee, issued the following news release on Jan. 19, 2022:
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Congressional Budget Office (CBO) released a report examining spending and prices for prescription drugs in the United States.
"This report drives home the urgent need to pass robust drug pricing reforms," Wyden said. "The . . .
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Congressional Budget Office (CBO) released a report examining spending and prices for prescription drugs in the United States.
"This report drives home the urgent need to pass robust drug pricing reforms," Wyden said. "The . . .